4//SEC Filing
Baranick Brian 4
Accession 0000950170-25-028172
CIK 0001124140other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 8:00 PM ET
Size
11.9 KB
Accession
0000950170-25-028172
Insider Transaction Report
Form 4
Baranick Brian
EVP, GM, Precision Oncology
Transactions
- Tax Payment
Common Stock
2025-02-25$51.28/sh−2,008$102,970→ 17,833 total - Award
Restricted Stock Units
2025-02-24+28,779→ 28,779 total→ Common Stock (28,779 underlying) - Exercise/Conversion
Restricted Stock Units
2025-02-25−3,954→ 3,955 total→ Common Stock (3,954 underlying) - Exercise/Conversion
Common Stock
2025-02-25+3,954→ 19,841 total
Holdings
- 670(indirect: By 401(k))
Common Stock
Footnotes (6)
- [F1]Represents shares of common stock received upon vesting of a restricted stock unit award.
- [F2]Represents shares of Common Stock retained by Exact Sciences Corporation for tax withholding purposes in connection with the net-settlement on the issuance of shares of Common Stock in respect to the vesting of certain restricted stock units.
- [F3]In addition to the shares of Common Stock reported on this Form 4, which total 18,503 shares, Mr. Baranick also holds, in the aggregate, an additional 88,103 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
- [F4]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F5]These restricted stock units vest in four equal annual installments beginning on February 27, 2026.
- [F6]Represents a restricted stock unit award granted on February 25, 2022 that vests in four equal annual installments from the grant date.
Documents
Issuer
EXACT SCIENCES CORP
CIK 0001124140
Entity typeother
Related Parties
1- filerCIK 0001941313
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 8:00 PM ET
- Size
- 11.9 KB